Clinical Trials Browser

Phase 1 × Gastroesophageal Adenocarcinoma × durvalumab × Clear all

NCT05733689 2026-03-10

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

Phase 1 Recruiting

Gastrointestinal

Gastroesophageal Adenocarcinoma